LeMaitre Vascular Q3 EPS $0.33 Beats $0.30 Estimate, Sales $47.41M Miss $47.59M Estimate
Portfolio Pulse from Benzinga Newsdesk
LeMaitre Vascular (NASDAQ:LMAT) reported Q3 earnings of $0.33 per share, beating the analyst consensus estimate of $0.30 by 10%. However, the company's quarterly sales of $47.41 million missed the analyst consensus estimate of $47.59 million by 0.38%.
November 01, 2023 | 9:40 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
LeMaitre Vascular's Q3 earnings beat estimates but sales missed expectations. This mixed result could lead to volatility in the stock's price.
LeMaitre Vascular's earnings beat estimates, which is a positive signal for investors. However, the company's sales missed expectations, which could be a concern. This mixed result could lead to uncertainty and volatility in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100